Pathogenesis of group A streptococci in mice and efficacy of locally administered streptococcal vaccines.
Bronze
M S
MS
VA Medical Center, Memphis, TN.
McKinsey
D S
DS
Beachey
E H
EH
Dale
J B
JB
D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D000942:Antigens, Bacterial / Q000276:immunology; D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins / Q000276:immunology; D001428:Bacterial Vaccines; D002352:Carrier Proteins; D007070:Immunoglobulin A / Q000032:analysis; D051379:Mice; D009297:Nasal Mucosa / Q000276:immunology / Q000382:microbiology; D012463:Saliva / Q000276:immunology; D013290:Streptococcal Infections / Q000276:immunology / Q000517:prevention & control*; D013297:Streptococcus pyogenes / Q000276:immunology / Q000472:pathogenicity*
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D002352:Carrier Proteins; D007070:Immunoglobulin A; C014689:streptococcal M protein